Immediate Impact

2 from Science/Nature 60 standout
Sub-graph 1 of 24

Citing Papers

Type 2 diabetes
2022 Standout
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
2022 Standout
2 intermediate papers

Works of R. Camisasca being referenced

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
2007
Pharmacologic Demonstration of the Synergistic Effects of a Combination of the Renin Inhibitor Aliskiren and the AT1 Receptor Antagonist Valsartan on the Angiotensin II–Renin Feedback Interruption
2004

Author Peers

Author Last Decade Papers Cites
R. Camisasca 296 1007 369 356 13 1.2k
Valentina Lukashevich 347 893 243 265 17 1.1k
A. Couturier 146 994 395 479 18 1.2k
Wolfgang Kothny 232 1402 396 438 31 1.6k
Kenneth Mace 156 1028 457 634 34 1.6k
Lisa E. Porter 275 1118 558 347 10 1.4k
H.J. Woerle 124 1591 729 690 31 1.7k
Mario N. Piccinni 251 825 560 313 31 1.3k
Maria Gerasimova 85 959 520 590 12 1.4k
Mette Zander 77 1070 388 583 13 1.3k
Paula Curtis 240 782 572 260 22 1.3k

All Works

Loading papers...

Rankless by CCL
2026